Whole Body Vibration Training
Behavioralwhole body vibration training and health education booklet
NCT Number: NCT07180485
This study focuses on whole body vibration training (WBVT), a form of neuromuscular training that uses mechanical vibrations. WBVT has been shown to improve muscle function, bone mineral density, and quality of life. While some benefits have been observed in the elderly population, there remains a research gap concerning its effectiveness in older adults with dynapenic abdominal obesity. Therefore, the findings of this study will provide new evidence for health interventions targeting this specific group.
This research targets outpatients aged 65 and above who meet the criteria for dynapenic abdominal obesity. It aims to evaluate the effects of WBVT on brain activity, osteoporosis, quality of life, and biological markers. The study period is from February 1, 2025, to January 31, 2027, with a planned sample size of 120 participants, equally divided into an experimental group and a control group (60 participants each).
Trial opening soon.
Get Notified65 year–100 year
All sexes
Interventional
Not applicable
The purpose of this study is to investigate the effects of whole body vibration training on older adults with dynapenic abdominal obesity in the following areas:
Brain activity: Changes in serum levels of brain-derived neurotrophic factor (BDNF).
Bone mineral density: Measured using dual-energy X-ray absorptiometry (DXA).
Quality of life: Assessed through questionnaires covering improvements in physical health, mental well-being, and social functioning.
Biomarkers: Changes in levels of total cholesterol, high- and low-density lipoprotein cholesterol, C-reactive protein (CRP), and glycated hemoglobin (HbA1c).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Outpatients aged 65 years or older
Diagnosed with dynapenic abdominal obesity
Able to understand and follow simple instructions
Able to communicate clearly and express their own will
Willing to sign the informed consent form
Exclusion criteria
Inability to communicate in Mandarin or Taiwanese, resulting in inability to participate in research activities
Severe visual or hearing impairment that hinders study participation
Presence of cognitive impairment, musculoskeletal or severe osteoporosis-related conditions
Refusal to sign the informed consent form
whole body vibration training and health education booklet
health education booklet
Time frame: 24 weeks
Total Cholesterol (TC) Time Frame: Baseline, 3 months, 6 months;Description: Serum total cholesterol level measured in mg/dL. Reference value: < 200 mg/dL.
Triglycerides (TG) Time Frame: Baseline, 3 months, 6 months;Description: Serum triglyceride level measured in mg/dL. Reference value: < 150 mg/dL.
Low-Density Lipoprotein Cholesterol (LDL-C) Time Frame: Baseline, 3 months, 6 months;Description: Serum LDL cholesterol measured in mg/dL. Reference value: < 130 mg/dL.
High-Density Lipoprotein Cholesterol (HDL-C)Time Frame: Baseline, 3 months, 6 months;Description: Serum HDL cholesterol measured in mg/dL. Reference values: > 40 mg/dL for men, > 50 mg/dL for women.
C-Reactive Protein (CRP)Time Frame: Baseline, 3months, 6 months;Description: Quantitative serum CRP level measured in mg/dL. Normal reference value: 0.3 mg/dL.
Glycated Hemoglobin (HbA1c)Time Frame: Baseline, 3 months, 6 months;Description: HbA1c percentage measured in blood. Normal Brain-Derived Neurotroph in pg/mL using
Time frame: 8 months
This study employed dual-energy X-ray absorptiometry (DXA), a widely used and clinically safe method for assessing bone health. The DXA system (brand referenced in previous publications) operates by emitting a low-radiation dose (±10 μSv) X-ray beam to measure the extent of X-ray penetration through body tissues. Based on the absorption data, the device calculates bone mineral density (BMD). Since bones absorb more X-rays and have high penetrability, while fat absorbs less and has low penetrability, DXA effectively differentiates between tissue types. DXA results are typically interpreted using T-scores for BMD. A T-score ≥ -1.0 indicates normal bone density and good skeletal health. A T-score between -2.5 and -1.0 suggests low bone mass (osteopenia), indicating a decreased BMD but not yet at the threshold for osteoporosis. A T-score ≤ -2.5 defines osteoporosis, indicating significantly reduced BMD and a higher risk of fractures. Severe osteoporosis is diagnosed when a T-score ≤ -2.5.
Time frame: 24 weeks
The Taiwan version of the World Health Organization Quality of Life questionnaire is a shortened version derived from the original 100-item WHOQOL-100 developed by the World Health Organization. Exploratory and confirmatory factor analyses of the questionnaire support a four-domain model consisting of physical health, psychological well-being, social relationships, and environment. The internal consistency (Cronbach's α) of these four domains ranges from 0.70 to 0.77. The questionnaire includes 28 items: one item for overall quality of life, one for general health, seven for physical health, six for psychological well-being, three for social relationships, and eight for environmental factors. The scale uses a 5-point Likert format based on frequency, intensity, capability, and evaluation. Higher scores indicate better quality of life.
Contact information is provided by the study sponsor or research team.
Dalin Tzu Chi General Hospital
Other
The Effectiveness of Whole Body Vibration Training in Improving Brain Activity, Bone Mineral Density, Quality of Life, and Biomarkers for the Older People With Dynapenic Abdominal Obesity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07534150
Dynapenia
Kaohsiung City, No. 100, Shiquan 1st Rd., Sanmin Dist., Kaohsiung City, Taiwan
View Trial DetailsNCT06621875
Atrophy, Dynapenia
View Trial DetailsNCT06682598
Behavior, Cognition Disorders
Porto Alegre, Rio Grande do Sul, Brazil
View Trial DetailsNCT07375888
Dynapenia
Kaohsiung City, Taiwan
View Trial Details